Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Starting soon Not applicable

Video Double-Lumen Tube for Secondary Pulmonary Resection

NCT07467005 · tracked via the Priya Life Science China tracker
Phase
Not applicable
Started
2026-03-16
Last updated
2026-03-12

Condition(s) studied

Lung CancerPulmonary Nodule

Investigational drug(s) / intervention(s)

Video Double-Lumen Tube GroupConventional Double-Lumen Tube Group

Video Double-Lumen Tube Group: Use the video double-lumen tube to perform left bronchial intubation under real-time visualization and continuously monitor its position.

Conventional Double-Lumen Tube Group: Insert a conventional left-sided double-lumen tube using standard intubation techniques.

Study summary

During thoracic surgery, double-lumen endotracheal intubation with one-lung ventilation is routinely performed to optimize surgical exposure, facilitate operative manipulation, and prevent iatrogenic lung injury. In patients undergoing repeat pulmonary surgery, prior lung resection may lead to pleural adhesions and tracheobronchial distortion, which substantially increase the difficulty of bronchial intubation. Even with experienced operators, the malposition rate of conventional double-lumen tubes remains high. The video double-lumen tube enables continuous visualization of the trachea and carina during insertion, positioning, and one-lung ventilation, allowing real-time airway monitoring. However, no clinical studies have specifically investigated airway management in patients undergoing redo pulmonary surgery. This study aimed to evaluate the efficacy and safety of the video double-lumen tube during anesthesia in patients undergoing secondary pulmonary resection.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥18 years. * History of previous pulmonary resection. * Scheduled for elective pulmonary surgery. * Planned to receive a left-sided double-lumen tube. * ASA physical status I-III. * Patients have signed the informed consent form. Exclusion Criteria: * Preoperatively predicted difficult airway (Mallampati ≥ III, Cormack-Lehane ≥ III). * Acute respiratory distress syndrome (ARDS) or respiratory failure within the past 3 months. * Uncontrolled asthma. * Confirmed pregnancy or current breastfeeding. * Multiple traumatic injuries. * Current participation in another clinical trial. * Other conditions deemed unsuitable by the investigator.

Primary outcome measure(s)

  • Success rate of first-attempt bronchial intubation — During the first intubation attempt

Trial sites (3)

FacilityCityRegionStatus
The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou Zhejiang
Zhejiang Cancer hospital Hangzhou Zhejiang
The Fourth Affiliated Hospital, Zhejiang University School of Medicine Yiwu Zhejiang
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07467005 on ClinicalTrials.gov ↗ ← All trials in China